Targeting gene expression to endothelium in transgenic animals: A comparison of the human ICAM-2, PECAM-1 and endoglin promoters

Xenotransplantation

Volumn 10, Issue 3, 2003, Pages 223-231

  Cowan, Peter J ^a,b   Shinkel, Trixie A ^a   Fisicaro, Nella ^a   Godwin, James W ^a   Bernabéu, Carmelo ^c   Almendro, Nuria ^c   Rius, Carlos ^c   Lonie, Andrew J ^d   Nottle, Mark B ^d   Wigley, Peter I ^d   Paizis, Kathy ^a,e   Pearse, Martin J ^a,f   D'Apice, Anthony J F ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^d Rundle Mall   (Australia)

^e AUSTIN RESEARCH INSTITUTE   (Australia)

^f CSL LIMITED   (Australia)

Author keywords

Endothelium; Porcine; Promoter; Transgenic; Xenotransplantation

Indexed keywords

CD31 ANTIGEN; DNA; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 2; REGULATOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL SUBPOPULATION; ENDOTHELIUM; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SWINE; TISSUE DISTRIBUTION; TRANSGENE; TRANSGENIC ANIMAL; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD59; AORTA; BLOOD VESSELS; CATS; CELL ADHESION MOLECULES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; SWINE; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 12444320404     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2003.01140.x     Document Type: Article

References (47)

1. DIAMOND L, QUINN C, MARTIN M et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71: 132.
2. CHEN RH, NAfiCY S, LOGAN JS, DIAMOND LE, ADAMS DH. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999; 6: 194.
3. COZZI E, TUCKER AW, LANGFORD GA et al. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 1997; 64: 1383.
4. BYRNE G, MCCURRY KR, MARTIN MJ et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63: 149.
5. COWAN PJ, AMINIAN A, BARLOW H et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504.
6. FODOR WL, WILLIAMS BL, MATIS LA et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153.
7. ADAMS DH, KADNER A, CHEN RH, FARIVAR RS. Human membrane cofactor protein (MCP, CD46) protects transgenic pig hearts from hyperacute rejection in primates. Xenotransplantation 2001; 8: 36.
8. SCHMOECKEL M, BHATTI FNK, ZAIDI A et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65: 1570.
9. COWAN PJ, SHINKEL TA, AMINIAN A et al. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone. Xenotransplantation 1998; 5: 184.
10. ANRATHER J, CSIZMADIA V, BROSTJAN C et al. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J Clin Invest 1997; 99: 763.
11. SOARES MP, MUNIAPPAN A, KACZMAREK E et al. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J Immunol 1998; 161: 4572.
12. DENK A, WIRTH T, BAUMANN B. NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev 2000; 11: 303.
13. BEG AA, SHA WC, BRONSON RT, GHOSH S, BALTIMORE D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995; 376: 167.
14. URLINGER S, BARON U, THELLMANN M et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000; 97: 7963.
15. KORHONEN J, LAHTINEN I, HALMEKYTO M et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood 1995; 86: 1828.
16. AIRD WC, JAHROUDI N, WEILER-GUETTLER H, RAYBURN HB, ROSENBERG RD. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA 1995; 92: 4567.
17. WEILER-GUETTLER H, AIRD WC, HUSAIN M, RAYBURN H, ROSENBERG RD. Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. Circulation Res 1996; 78: 180.
18. GORY S, VERNET M, LAURENT M, DEJANA E, DALMON J, HUBER P. The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. Blood 1999; 93: 184.
19. COWAN PJ, SHINKEL TA, WITORT EJ et al. Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter. Transplantation 1996; 62: 155.
20. COWAN PJ, TSANG D, PEDIC CM et al. The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites. J Biol Chem 1998; 273: 11737.
21. NEWMAN PJ. The biology of PECAM-1. J Clin Invest 1997; 99: 3.
22. GOUGOS A, LETARTE M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 1988; 141: 1925.
23. ALMENDRO N, BELLON T, RIUS C et al. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression - structural and functional characterization. J Immunol 1996; 157: 5411.
24. RIUS C, SMITH JD, ALMENDRO N et al. Cloning of the promoter region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood 1998; 92: 4677.
25. VELASCO B, RAMIREZ JR, RELLOSO M et al. Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters. Gene Ther 2001; 8: 897.
26. Loss M, VANGEROW B, SCHMIDTKO J et al. Acute vascular rejection of h-DAF transgenic porcine kidneys in immunosuppressed cynomolgus monkeys is associated with systemic and intragraft complement activation. Transplant Proc 2001; 33: 715.
27. COWAN PJ, SOMERVILLE CA, SHINKEL TA et al. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 826.
28. BRODBECK WG, MOLD C, ATKINSON JP, MEDOF ME. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J Immunol 2000; 165: 3999.
29. SHINKEL TA, COWAN PJ, BARLOW H et al. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice. Transplantation 1998; 66: 1401.
30. NOTTLE MB, NAGASHIMA H, KASHIWAZAKI N et al. Production of pigs containing a metallothionein porcine growth hormone gene construct. Proc 26th Ann Conf Aust Soc Reprod Biol 1994; 26: 33.
31. DELISSER HM, NEWMAN PJ, ALBELDA SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994; 15: 490.
32. O'CONNELL PJ, MCKENZIE A, FISICARO N et al. Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation molecule. Clin Exp Immunol 1992; 90: 154.
33. CHEN D, RIESBECK K, MCVEY JH et al. Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins. Transplantation 1999; 68: 832.
34. SHARMA A, OKABE J, BIRCH P et al. Reduction in the level of Gal(alpha 1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190.
35. MURAKAMI H, TAKAHAGI Y, YOSHITATSU M et al. Porcine MCP gene promoter directs high level expression of human DAF (CD55) in transgenic mice. Immunobiology 2000; 201: 583.
36. NOTTLE MB, VERMA PJ, DU Z-T et al. Production of pigs expressing multiple transgenes for use in xenotransplantation studies. Theriogenology 1999; 51: 422.
37. JANEL N, DOSNE AM, OBERT B, MEYER D, KERBIRIOU-NABIAS D. Functional characterization of bovine von Willebrand factor gene promoter in bovine endothelial cells demonstrates species-specific properties. Gene 1997; 198: 127.
38. PAN J, XIA L, MCEVER RP. Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J Biol Chem 1998; 273: 10058.
39. HE Z, SHE R, SUMITRAN-HOLGERSSON S et al. The in vitro activity and specificity of human endothelial cell-specific promoters in porcine cells. Xenotransplantation 2001; 8: 202.
40. STOCKER CJ, SUGARS KL, YARWOOD H et al. Cloning of porcine intercellular adhesion molecule-1 and characterization of its induction on endothelial cells by cytokines. Transplantation 2000; 70: 579.
41. XU H, BICKFORD JK, LUTHER E et al. Characterization of murine intercellular adhesion molecule-2. J Immunol 1996; 156: 4909.
42. GERWIN N, GONZALO J-A, LLOYD C et al. Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2-deficient mice results in extended hyperresponsiveness. Immunity 1999; 10: 9.
43. GEIJTENBEEK T, KROOSHOOP D, BLEIJS D et al. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nature Immunol 2000; 1: 353.
44. DAGDEVIREN A, MUFTUOGLU SF, CAKAR AN, ORS U. Endoglin (CD105) expression in human lymphoid organs and placenta. Anat Anz 1998; 180: 461.
45. IZAWA D, TANAKA T, SAITO K et al. Expression profile of active genes in mouse lymph node high endothelial cells. Int Immunol 1999; 11: 1989.
46. WESTPHAL JR, WILLEMS HW, SCHALKWIJK CJ, RUITER DJ, DE WAAL RM. Characteristics and possible function of endoglin, a TGF-beta binding protein. Behring Inst Mitt 1993; 92: 15.
47. ROSE AG, COOPER DKC. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000; 7: 31.